✦ LIBER ✦

Prolonged cytogenetic and hematologic remission of blastic transformation in chronic granulogytic leukemia

✍ Scribed by George P. Canellos; Jacqueline Whang-Peng; Lowell Schnipper; Clarence H. Brown III

Publisher: John Wiley and Sons
Year: 1972
Tongue: English
Weight: 520 KB
Volume: 30
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(197207)30:1<288::aid-cncr2820300140>3.0.co;2-a

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clonal changes in chronic granulocytic l

Clonal changes in chronic granulocytic leukemia in blastic transformation and during remission

✍ German Beltran; Maria Varela 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 629 KB

Current status of blastic transformation

Current status of blastic transformation in chronic myelogenous leukemia

✍ James C. Barton; Marcel E. Conrad 📂 Article 📅 1978 🏛 John Wiley and Sons 🌐 English ⚖ 910 KB

A long-lasting, complete hematologic and

A long-lasting, complete hematologic and cytogenetic remission of chronic myelogenous leukemia after treatment with busulfan alone

✍ C. M. P. W. Mandigers; E. J. B. M. Mensink; A. Geurts van Kessel; D. C. van der 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 144 KB

Heterogeneity of morphological, cytochem

Heterogeneity of morphological, cytochemical, and cytogenetic features in the blastic phase of chronic granulocytic leukemia

✍ Michael T. Shaw; Richard H. Bottomley; Petre N. Grozea; Robert E. Nordquist 📂 Article 📅 1975 🏛 John Wiley and Sons 🌐 English ⚖ 752 KB

Hematologic remission and cytogenetic im

Hematologic remission and cytogenetic improvement after treatment of stable-phase chronic myelogenous leukemia with continuous infusion of low-dose cytarabine

✍ Michael J. Robertson; Ramana Tantravahi; James D. Griffin; George P. Canellos; D 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 722 KB

Chronic myelogenous leukemia in T cell l

Chronic myelogenous leukemia in T cell lymphoid blastic phase achieving durable complete cytogenetic and molecular remission with imatinib mesylate (STI571; Gleevec) therapy

✍ Ehab Atallah; Moshe Talpaz; Susan O'brien; Mary Beth Rios; Jie Qiang Guo; Ralph 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

## Abstract ## BACKGROUND A T cell lymphoid blastic phase of chronic myelogenous leukemia (CML) is a rare occurrence, with only a few reported cases worldwide. Standard therapy for such patients is undetermined. Imatinib mesylate, a Bcr‐Abl tyrosine kinase inhibitor, has shown activity in CML. ##